Form4insider filings, from the source

SEC Form 5 · accession 0001104659-17-009362

Diplomat Pharmacy, Inc. · DPLO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Philip R Hagerman
Officer — Chairman and CEO · Director · 10% Owner
Period of report
Dec 31, 2016
Accepted (ET)
Feb 14, 2017 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3Aug 24, 2016G734,513$0.00D0IPhilip Hagerman 2014 GRAT
Common StockF4,F2Aug 24, 2016G734,513$0.00D0IJocelyn Hagerman 2014 GRAT
Common StockF1,F4Aug 24, 2016G367,256$0.00A367,256IIrrevocable Non-Exempt Trust for Son
Common StockF1,F4Aug 24, 2016G367,256$0.00A367,256IIrrevocable Non-Exempt Trust for Daughter
Common StockF1,F2holding———1,499,756IPhilip R. Hagerman Revocable Trust
Common StockF3holding———3,891,609I2007 Hagerman Family GST Trust
Common StockF2holding———4,450,091IThe JH GST Trust
Common StockF3holding———1,550,876I2013 Irrev. Exempt Trust for Daughter
Common StockF3holding———1,550,876I2013 Irrev. Exempt Trust for Son
Common StockF2holding———1,215,293I2013 Irrev. Exempt Trust for Daughter
Common StockF2holding———1,371,292I2013 Irrev. Exempt Trust for Daughter
Common StockF3holding———313,337I2014 Irrev. Exempt Trust for Son
Common StockF3holding———313,337I2014 Irrev. Exempt Trust for Daughter
Common StockF2holding———313,337I2014 Irrev. Exempt Trust for Daughter
Common StockF2holding———313,337I2014 Irrev. Exempt Trust for Daughter
Common StockF4,F3holding———696,659IJocelyn Hagerman Living Trust
Common StockF2holding———301,212IPhilip R. Hagerman Living Trust
Common StockF2holding———263,500IJH Marital Trust
Common StockF3holding———272,000IPH Marital Trust
Common Stockholding———394,910IIrrevocable Trust for Son
Common Stockholding———394,910IIrrevocable Trust for Daughter

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses